Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,039 | 82,330 | 54,875 | 82,777 | 62,745 |
| Marketable Securities | 163,557 | 251,000 | 355,948 | 395,420 | 220,657 |
| Receivables | 17,207 | 12,769 | 8,458 | 2,431 | N/A |
| Inventories | 10,474 | 8,551 | 7,514 | 4,307 | N/A |
| TOTAL | $308,868 | $367,676 | $437,406 | $496,719 | $295,426 |
| Non-Current Assets | |||||
| PPE Net | 1,867 | 2,070 | 1,881 | 1,939 | 2,078 |
| Intangibles | 6,812 | 7,000 | 7,188 | 7,375 | 0 |
| Other Non-Current Assets | 3,142 | 2,712 | 2,799 | 2,881 | 2,960 |
| TOTAL | $11,821 | $11,782 | $11,868 | $12,195 | $5,038 |
| Total Assets | $320,689 | $379,458 | $449,274 | $508,914 | $300,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,156 | 12,485 | 8,827 | 8,666 | 8,437 |
| Accrued Expenses | 18,808 | 23,864 | 28,323 | 27,797 | 18,463 |
| TOTAL | $36,659 | $37,025 | $37,807 | $37,102 | $27,482 |
| Non-Current Liabilities | |||||
| Long Term Debt | 199,767 | 198,763 | 197,769 | 196,753 | 73,138 |
| Other Non-Current Liabilities | 3,755 | 3,938 | 4,117 | 4,285 | 4,462 |
| TOTAL | $203,522 | $202,701 | $201,886 | $201,038 | $77,600 |
| Total Liabilities | $240,181 | $239,726 | $239,693 | $238,140 | $105,082 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,654 | 61,422 | 61,083 | 60,928 | 51,563 |
| Common Shares | 6 | 6 | 6 | 6 | 5 |
| Retained earnings | -870,855 | -799,864 | -719,764 | -647,745 | -540,036 |
| Other shareholders' equity | -292 | -414 | -1,086 | -1,596 | -1,252 |
| TOTAL | $80,508 | $139,732 | $209,581 | $270,774 | $195,382 |
| Total Liabilities And Equity | $320,689 | $379,458 | $449,274 | $508,914 | $300,464 |